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1 Abstract
In microarray experiments, it is often of interest to identify genes which have a pre-
specified gene expression profile with respect to time. Methods available in the litera-
ture are, however, typically not stringent enough in identifying such genes, particularly
when the profile requires equivalence of gene expression levels at certain time points. In
this paper, the authors introduce a new methodology, called gene profiling, that uses
simultaneous differential and equivalent gene expression level testing to rank genes ac-
cording to a pre-specified gene expression profile. Gene profiling treats the vector of
true gene expression levels as a linear combination of appropriate vectors, i.e., vectors
that give the required criteria for the profile. This gene-profile model is fitted to the
data and the resultant parameter estimates are summarized in a single test statistic
that is then used to rank the genes. The theoretical underpinnings of gene profiling
(equivalence testing, intersection-union tests) are discussed in this paper, and the gene
profiling methodology is applied to our motivating stem cell experiment.
Keywords: Gene expression; Gene profiling; Linear model; Microarray; Pluripotency;
Stem cell; Time course experiment.
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2 Introduction
Microarray technology enables researchers to examine the expression levels for many
thousands of genes simultaneously (see, for example, Nguyen et al., 2002; Smyth et al.,
2003). Increasingly, information on gene expression is used to infer cell protein lev-
els and thus cellular behaviour (Nguyen et al., 2002; Smyth et al., 2003; Ahnert et al.,
2006; McLachlan et al., 2006). A further major area of interest is in investigating
changes in gene expression levels over time in a population of cells (Dudoit et al., 2002;
Bar-Joseph et al., 2003; Glonek and Solomon, 2004; Tai and Speed, 2005; Ernst et al.,
2005; Brown et al., 2006; Ahnert et al., 2006) and this is the subject of the present pa-
per. We refer to the gene expression levels over time as a gene expression profile, or
profile for short.
Several methods of analysing gene expression profiles fall into the class of tech-
niques known as unsupervised learning methods. These methods seek to group genes
into a number of classes based upon their observed profiles. Some of the methodologies
discussed in the recent microarray literature are hierarchical classification (Eisen et al.,
1998), self-organizing maps (Tamayo et al., 1999), theK-means algorithm (Tavazoie et al.,
1999), multivariate Gaussian mixtures (Ghosh and Chinnaiyan, 2002; Yeung et al., 2001),
and mixtures of linear mixed models (Celeux et al., 2005). A related problem that arises
in applications of microarray time course experiments is to specify, in advance, a gene
expression profile of interest and then to identify the genes with matching expression
profiles. However, unsupervised methods do not address this problem and various al-
ternative approaches have been proposed.
One such method is Pareto optimization, proposed by Fleury et al. (2002) and
Hero and Fleury (2004), in which a set of functions, each measuring the association
of a gene to a pre-specified profile, is chosen. Genes found to be Pareto-optimal with
respect to these criteria are identified as matching the pre-specified profile. The main
disadvantage with Pareto optimization is that some genes will be selected as Pareto-
optimal genes whilst only matching the pre-specified profile for a subset of the profile’s
criteria.
In an unpublished paper, Lo¨nnstedt et al. (2003) describe a different method for
ranking genes, based on the inner product between the vector of observed log ratios and
a pre-specified profile. This method works well for some profiles, but did not provide
useful outcomes in our application.
Gene profiling is a new approach developed by the present authors, which aims to
identify genes that match a pre-specified gene expression profile, with greater specificity
than the previously described approaches. Gene profiling entails treating the vector of
true gene expression levels for each gene as a linear combination of linearly independent
vectors chosen to represent the pre-specified profile. The gene-profile model is fitted
to the observed log ratios, and the genes are ranked by a single test statistic which
incorporates simultaneous differential and equivalent gene expression testing.
In Section 3, our motivation for gene profiling is presented. Section 3.1 sets out the
details of the experimental design for a pluripotent (stem cell) time course experiment
which provided our initial motivation for the ensuing methodological development. The
theoretical underpinnings of gene profiling are described in Section 4, which entails a
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review of equivalence testing (Section 4.2) and intersection-union tests (Section 4.3).
The gene profiling methodology is set out in Section 4.4, and the results obtained from
our application to a stem cell experiment are presented in Section 5. In Section 6, some
further work and how to apply the methods in limma are briefly discussed.
3 Motivation: pluripotency
Our motivating example is a stem cell experiment originally conducted by the Rath-
jen laboratory, formerly of the University of Adelaide. The aim of the experiment was to
identify genes associated with pluripotency in mice embryonic stem cells (D’Amour and Gage,
2003; Ramalho-Santos et al., 2002). Early stem cells have the potential to differentiate
into any body cell: a property known as pluripotency. This ability is present in mice
stem cells up to and including day three. After this the stem cells become multipotent:
they still have the ability to differentiate into different types of cells, but now a limited
number. For example, haemopoetic stem cells can differentiate into blood cells but
not nerve cells. As pluripotency is restricted to the early stem cells, day 3 or earlier,
genes that have high expression levels in cells up to day 3, but low, or monotonically
decreasing expression levels thereafter, are likely to be associated with the biochemical
pathways involved in the pluripotency ability of these cells (personal communication,
Dr Chris Wilkinson).
3.1 Pluripotency example: experimental design
Stem cells were isolated from the early embryo and grown in culture dishes. The cells
were allowed to replicate and grow over the medium in the dish. Once the cells had
crowded the plate, they were removed, separated and plated onto new plates. This
cycle of growth and re-plating is called a passage. The Rathjen laboratory isolated mice
embryonic stem cells, and for this experiment, used cells from passages 21, 22, 23 and
24. The cells were stimulated to differentiate into multipotent cells, and on days 0, 3, 6
and 9 after stimulation, samples were taken and the messenger RNA (mRNA) obtained.
The gene expressions of the 16 samples of stem cell mRNA for the four days (0, 3, 6,
9) and four passages, were measured. Within each passage, five comparisons were made,
namely, day 0 to day 3, day 0 to day 9, day 3 to day 6, day 3 to day 9, and day 6 to day
9. The experimental design in terms of the true gene expression levels, µ (see Section 4)
is summarized in Figure 1, while the experimental design in terms of the gene profiling
parameters, γ (Section 4), is compared to the design in terms of the true expression levels
in Table 1. The clone library used in the experiment was the Compugen 22,000 mouse
oligonucleotide library (http://www.microarray.adelaide.edu.au/libraries/). In total, 20
arrays were hybridized on two-colour long-oligonucleotide microarrays, with five arrays
within each passage. The five arrays consisted of the five comparisons detailed above.
In this analysis, the stem cells from each passage were treated as independent biological
replicates.
3
µ0
µ9
µ3
µ6
Figure 1: Microarray comparisons made within each passage for the pluripotency stem
cell experiment. Each arrow represents two arrays, one for each passage (passage 21/22
continuous arrow, passage 23/24 dashed arrow), with the arrow head pointing to the
sample labeled with cy5, and the sample at the arrow tail labeled with cy3. Day 0, 3,
6, and 9 are represented by µ0, µ3, µ6, and µ9 respectively.
Day Parameterization Parameterization
in terms of µ’s in terms of γ’s
0 µ0 γ0 + γ1 + γ2 +
1
2γ3
3 µ3 γ0 + γ1 + γ2 −
1
2γ3
6 µ6 γ0 + γ2
9 µ9 γ0
Table 1: Parameterization of stem cell experiment in terms of absolute mean gene ex-
pressions (µi, i = 0, 3, 6, 9) and in terms of the gene profile coefficients (γi, i = 0, 1, 2, 3).
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4 Gene profiling methodology
4.1 Development of method for stem cell experiment
The expression criteria over time required for a pluripotent gene are:
• equal gene expression levels for days 0 and 3,
• higher gene expression levels for days 0 and 3 compared to day 9, and
• the gene expression level for day 6 to lie between the gene expression levels for
day 0 and day 3, and the gene expression level for day 9.
The requisite (hypothetical) profile is illustrated in Figure 2.
Consider the vector of true mean gene expression levels, µ = (µ0, µ3, µ6, µ9)
′, where
µi, i = 0, 3, 6, 9 is the mean gene expression level on day i as shown in Figure 1. Since
this is a vector in R4, it can be expressed as the linear combination of four linearly
independent vectors. The first step in gene profiling is to choose vectors that represent
the criteria for pluripotency. In the present example, this corresponds to
µ = γ0


1
1
1
1

+ γ1


1
1
0
0

+ γ2


1
1
1
0

+ γ3


1/2
-1/2
0
0

 . (4.1)
With this choice of model, it follows that γ0 = µ9, γ1 = (µ0 + µ3)/2− µ6, γ2 = µ6 − µ9,
and γ3 = µ0−µ3. Therefore, the pluripotent profile requires that γ1 > 0, γ2 > 0, γ3 = 0,
but does not constrain γ0. To find genes that achieve these criteria requires tests for
equivalence as well as (simultaneous) tests for differential gene expression. In the next
section, equivalence testing is discussed. We then describe how to simultaneously test
for both differential and equivalent gene expression in a time course experiment.
4.2 Statistical Equivalence
To determine pluripotency, it is necessary to demonstrate that γ3 = 0. Conventional hy-
pothesis testing is not applicable to this situation, but the equivalence testing approach
discussed in Wellek (2002) is.
If X is a random vector whose probability distribution depends on a real-valued
parameter θ, then to test if θ is equivalent to zero, a neighbourhood around zero is
constructed and the following null and alternative hypotheses are tested:
H0 : |θ| ≥ ǫ, ǫ > 0, (4.2)
Ha : |θ| < ǫ.
The neighbourhood defined by ǫ is the maximum that the parameter can vary and still
be considered equivalent to zero. This neighbourhood is necessary to ensure that the
power of the statistical test is greater than its significance level (Wellek, 2002).
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Figure 2: The pre-specified gene expression profile for pluripotent genes. For each day,
the log ratio with respect to day 0 is plotted.
For the gene profiling model, the parameter ǫ is taken to be the largest that a gene’s
mean log ratio can vary around zero and not be of “significant” gene expression, ac-
cording to biologists. In practice, a working understanding of equivalent gene expression
should be decided upon in advance in consultation with biologists. Unfortunately how-
ever, relatively little is known about gene-specific variation per se: information that
could of course be used to decide on an appropriate value of ǫ. We discuss potentially
suitable choices of ǫ in Section 5, but for the present we will assume an appropriate ǫ
to be available. Using such a value of ǫ, the simplest and most common way to test the
hypotheses in (4.2) is via Confidence Interval Inclusion (CII).
Consider the null and alternative hypotheses specified in (4.2). We calculate a
confidence interval, Rα(X), from the observed data X, where
Rα(X) = (Lα(X), Uα(X)) ; (4.3)
Lα(X) and Uα(X) are random variables, such that
P (θ ∈ (Lα(X),∞)) = P (θ ∈ (-∞, Uα(X))) = 1− α.
We reject the null hypothesis in favour of equivalence if and only if
Rα(X) ⊂ (-ǫ, ǫ),
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i.e., the confidence interval is contained entirely within the interval (-ǫ, ǫ). This is an
α-level test.
The equivalence formulation can be used to test that γ3 in equation (4.1) is equivalent
to zero with the following null and alternative hypotheses:
H0 : |γ3| ≥ ǫ vs. Ha : |γ3| < ǫ. (4.4)
For example, to test the hypotheses in (4.4), the confidence interval
(γˆ3 − t
∗SE(γˆ3), γˆ3 + t
∗SE(γˆ3)) ,
is calculated and γ3 is concluded to be equivalent to zero if this confidence interval lies
within (-ǫ, ǫ). In this confidence interval, t∗ is chosen such that P (T > t∗) = α, where
T has a t-distribution with the appropriate degrees of freedom for γ3.
Confidence interval inclusion can also be used to (separately) test whether γ1 and
γ2 are significantly positive. The null and alternative composite hypotheses for γ1 are
H0 : γ1 ≤ 0 vs. Ha : γ1 > 0,
and for γ2 are
H0 : γ2 ≤ 0 vs. Ha : γ2 > 0.
For an α-level test here, a one-sided (1−α)100% confidence interval for γ1 is calcu-
lated:
(γˆ1 − t
∗SE(γˆ1),∞) ,
and if this interval is contained in (0,∞), γ1 is concluded to be significantly positive.
Similarly for γ2.
These methods allow testing of each criterion separately, but for pluripotency all
three criteria need to be valid simultaneously. The authors’ method to simultaneously
test for both equivalence of parameters to zero and significant departures of parameters
from zero is described in the next section.
4.3 Intersection-Union test
The test for each criterion discussed in Section 4.2 can be incorporated simultaneously
into a single null and a single alternative hypothesis as follows:
H0 : (γ1 ≤ 0)
⋃
(γ2 ≤ 0)
⋃
(|γ3| ≥ ǫ) , ǫ > 0, (4.5)
versus Ha : (γ1 > 0)
⋂
(γ2 > 0)
⋂
(|γ3| < ǫ) . (4.6)
The hypotheses in (4.5) and (4.6) represent an intersection-union test (IUT)(Berger,
1982). To review, in an IUT, the null hypothesis is expressed as a union,
H0 : θ ∈
⋃
γ∈Γ
Θγ ,
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where Θγ is a subset of the parameter space indexed by γ. The rejection region R of
this IUT is of the form R =
⋂
γ∈ΓRγ , where Rγ is the rejection region for a test of
H0γ : θ ∈ Θγ versus H1γ : θ ∈ Θ
c
γ . This is an α-level test, where α = supγ∈Γαγ and αγ
is the size of the test H0γ , with rejection region Rγ .
Thus for each γi, i = 1, 2, 3, in the null hypothesis statement (4.5), a test of size
αi is found, and the overall IUT will be of level sup αi. Using the confidence interval
inclusion method discussed in the previous section to test each γi separately, each test
being of level α, gives an overall α-level test.
Our main aim is to rank the genes in our motivating example according to their
match with the pluripotent profile. The testing methodology described can be modified
to give a quantitative measure of how closely each gene matches the desired profile.
Considering each gene separately, for each parameter, γi, i = 1, 2, 3, confidence interval
inclusion is used to test the associated null hypothesis. Rather than using a fixed
significance level, the smallest significance level, αi, for each γi, i = 1, 2, 3 respectively,
is found, such that the null hypothesis is rejected. The supremum of αi, i = 1, 2, 3 is
used as the test statistic to rank the genes. In fact, in the stem cell experiment, rather
than calculate αi for each γi, i = 1, 2, 3, the width of the largest confidence interval, Ui,
for each γi that was contained within the rejection region was used. The infimum, U,
of the Ui was then used to rank the genes (it should be noted that this is equivalent to
ranking based on supαi).
To further elucidate the method, consider Figure 3. This illustrates a two-dimensional
example where the criteria are γ1 = 0 and γ2 > 0. The rejection region is indicated
by the rectangular shaded region. The point (γˆ1, γˆ2) is the estimate of (γ1, γ2). The
distance to the nearest boundary of the rejection region is calculated in standard errors
of the estimate and this distance is used to rank the genes, with larger values indicative
of association with pluripotency. Genes whose profiles do not lie within the rejection
region are excluded from the ranking.
The above development leads to the general methodology for determining pluripo-
tency described in the next section.
Rejection region
γ2
γ1
(γˆ1, γˆ2)
ǫ-ǫ
Figure 3: Illustration: for each gene, the distance from (γˆ1, γˆ2) to the nearest boundary
of the rejection region is used to rank the genes.
8
4.4 Gene profiling for pluripotency
The scanned images for each hybridized microarray slide were analysed using SPOT
(Yang et al., 2001) to give the cy3 and cy5 intensities for each gene (Yang et al., 2001;
Adams and Bischof, 1994). The data were then normalized by within-array print-tip
loess, and the gene profile model was fitted to the normalized data using limma (Smyth,
2005) in R (R Development Core Team, 2006). For each gene, the model parameter
estimates and standard errors obtained by limma were used to calculate the U statistic
(see below) using C code embedded in R code. The genes were then ranked using the
U statistic.
The vector of observed log ratios M was expressed as a linear model of the true
gene expression levels µ as follows:
M = X∗µ+E,
where X∗ is the design matrix representing the mRNA comparisons made on each array,
and E is assumed to be distributed as N20(0, σ
2I). Using equation (4.1) to substitute
for µ, gives
M = X∗


1 1 1 1/2
1 1 1 -1/2
1 0 1 0
1 0 0 0




γ0
γ1
γ2
γ3

+E
= Xγ +E.
In the stem cell experiment, the microarray platform used was two-colour long oligonu-
cleotide which, as for cDNA microarrays, measures relative gene expression, but not
absolute gene expression levels. Therefore, the overall gene expression level, γ0, could
not be estimated and was removed from the model by changing the parameter vector
to (γ1, γ2, γ3) and removing the first column of X.
Estimates of γ were calculated via least squares, and the estimate of σ2 was ob-
tained using the empirical Bayes method utilized in limma; this gives a robust posterior
estimate of σ2 based on a prior which “borrows” information from the observed variance
of all the genes on the array.
For each gene, three tests statistics, U1, U2 and U3 were calculated as follows:
U1 =
γˆ1
SE(γˆ1)
, U2 =
γˆ2
SE(γˆ2)
, U3 =
ǫ− |γˆ3|
SE(γˆ3)
,
where SE(γˆi) is the ith diagonal element of the square matrix: s
√
(X ′X)-1, and s is the
posterior estimate of σ. The minimum of Ui, i = 1, 2, 3, is used to rank the genes, for
which genes with larger values of U are more likely to be associated with pluripotency.
Genes whose estimate (γˆ1, γˆ2, γˆ3) of (γ1, γ2, γ3) did not lie within the rejection region,
i.e. those genes for which at least one Ui, i = 1, 2, 3 was negative, were excluded from
the ranking.
5 Application: determining genes associated with pluripo-
tency using gene profiling
The model (4.1) was fitted to the stem cell data with ǫ = 1. In addition, the test
statistics were changed to test for γ2 > 1.5, i.e., U2 =
γˆ2−1.5
SE(γˆ2)
. The value of 1.5 was
chosen to ensure a large difference between the gene expression levels on days 0, 3 and
6 compared with the gene expression level on day 9.
The ranked genes are given in Table 2, and the fitted profiles for these 15 genes are
shown in Figure 4. Figure 4 shows the fitted log ratios with respect to day 0 for the
four time points: day 0, day 3, day 6, and day 9. Therefore, all of the profiles will
pass through zero on day 0. The profiles demonstrate the required trajectory: equal
expression for day 0 and day 3, higher gene expression levels for days 0 and 3 compared
to day 9, and the gene expression level for day 6 lying between the gene expression levels
for days 0 and 3 and that for day 9.
Gene Names γˆ1 γˆ2 γˆ3 U
Oct4 0.48 2.77 0.20 2.53
Utf1 0.54 1.82 −0.42 2.46
Tdgf1 1.04 1.88 0.22 1.80
Slc35f2 0.32 1.69 −0.17 1.53
Trh 0.44 1.71 −0.69 1.50
Foxd3 0.14 1.79 −0.17 1.33
Musd1 0.15 2.00 −0.62 1.17
Skil 0.15 1.66 −0.83 1.16
Pou6f1 0.54 1.66 0.24 1.13
Par2 0.33 1.58 0.60 0.75
Nanog 0.31 1.99 0.88 0.69
Slc7a3 0.09 2.45 −0.58 0.67
Gng3 0.15 1.55 −0.42 0.33
Skil 0.23 1.54 −0.74 0.28
Rae-28 0.14 1.51 −0.29 0.08
Table 2: The ranked genes from fitting pluripotent profile (4.1) to the stem cell data.
The top-ranked gene, Oct4, is well-known to be associated with pluripotency (Rodda et al.,
2005; Loh et al., 2006) and would therefore be expected to appear amongst the top-
ranked genes for pluripotency in this experiment. Other genes of note in the ranked
genes in Table 2 are Utf1 (rank 2) which is associated with undifferentiated embry-
onic cell transcription (Nishimoto et al., 2005), and Nanog (rank 11) which is central to
embryonic stem cell pluripotency (Wang et al., 2006).
The recent article by Wang et al. (2006) isolated proteins associated with the protein
Nanog and thus with pluripotency. Of the 38 proteins discussed in Wang et al. (2006),
Oct4 and Nanog appeared in our list of ranked genes using model (4.1): ranks 1 and 11
respectively. The remaining proteins were not in the ranked genes as the profiles of the
10
associated mRNAs are not consistent with profile (4.1).
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Figure 4: Fitted log ratios with respect to day 0 for the ranked genes for the pluripotency
profile (4.1).
Sensitivity analysis: As stressed previously, the choice of the neighbourhood around
zero assumed for equivalence (i.e., ǫ) should be decided upon in consultation with bi-
ologists. However, this is problematic since biologists still have relatively little explicit
knowledge of gene-wise expression variability, and therefore, what precisely and quan-
titatively may represent equivalence of gene expression.
To investigate the potential effects of altering the neighbourhood defined by ǫ, the
primary analysis was repeated assuming, respectively, values of ǫ = 0.5, 1, 1.5, and 2.
In Figure 5 the profiles for the genes which have observed profiles that lie within the
rejection region are plotted for each choice of equivalence neighbourhood. As the equiv-
alence neighbourhood width (ǫ) increases, more genes have profiles that lie within the
rejection region, but there is greater variation between the gene expression levels for
day 0 and day 3. Nevertheless, gene profiling in this application has been demonstrated
to be reasonably robust. For ǫ=0.5, 1 and 1.5, Oct4 was ranked as the top gene, while
for ǫ=2, it had only dropped to rank 2.
Profiling for Sox2: It is well known that the gene Sox2 is commonly associated with
pluripotency (Rodda et al., 2005), but it was not in the ranked genes using the gene
expression profile (4.1): the fitted gene expression profile for Sox2 is very different from
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Figure 5: Fitted log ratios with respect to day 0 for the ranked genes with (a) ǫ = 0.5,
(b) ǫ = 1, (c) ǫ = 1.5, and (d) ǫ = 2.
the pluripotent profile used in the analysis. The criteria for the profile of Sox2 are:
higher gene expression level on day 0 compared to the gene expression levels for days 6
and 9; equivalent gene expression levels on days 6 and 9; and the gene expression level
for day 3 to lie between the gene expression level for day 0 and the levels for days 6 and
9. Gene profiling can be used to rank the genes according to these alternative criteria.
An appropriate model for Sox2 is:
µ =


1 1 1 0
1 0 1 0
1 0 0 12
1 0 0 -12

γ,
in which γ0 is unrestrained, γ1 > 0, γ2 > 0, and γ3 is equivalent to zero. This
model was fitted to the data and the ranked genes are shown in Figure 6. The ranked
genes were Cpt1a, 1200014E20Rik, 2210409E12Rik, Sox-2, Np-1, Birc5, 5730419I09Rik,
MGI:1922156, retSDR3, and clone RP21-505L19 on chromosome 5. Sox2 was ranked at
12
position 4. Of note is retSDR3. This gene has the required form with a larger difference
in gene expression between day 0 and days 6 and 9 compared to the other genes. Even
with this large difference, retSDR3 is low down in the ranking at rank 9. This low
ranking is because retSDR3 has a large gene expression variance (0.181) compared to
the other ranked genes (average gene expression variance of 0.054). This illustrates that
if two genes have the same coefficient values, gene profiling will rank lower the gene
which has the larger variance and thus more uncertainty about its true profile.
Birc5
1200014E20Rik
Sox2
2210409E12Rik
Cpt1a
5730419I09Rik
MGI:1922156
Np-1
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Figure 6: Fitted log ratios with respect to day 0 for the top 10 ranked genes for the
Sox2 profile.
6 Discussion of further work
In general, gene profiles of interest to molecular biologists often consist of two types of
criteria: equal gene expression at different time points and differential gene expression
at different time points. Gene profiling provides a straightforward methodology to filter
genes which satisfy these two types of criteria simultaneously. We believe that this has
not been accomplished using previously available techniques. By simultaneously testing
for all criteria, gene profiling effectively filters out and excludes genes that are only
partially consistent with the required profile. We now touch on some areas requiring
further work.
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Choice of ǫ: As noted in Section 4.3, to test for a parameter being equal to zero,
a neighbourhood of width ǫ is defined. This neighbourhood is the amount that the
parameter could vary and still be considered equivalent to zero. In this paper, the
choice of ǫ was based on plotting profiles for the various choices of ǫ, and choosing
the best ǫ to give the required pre-specified profiles. Ideally, the choice of ǫ should be
based on consultation with biologists, to the extent that such knowledge is available.
One would anticipate that such requisite knowledge will gradually accrue over time, as
microarray and other new genomics technologies are more widely applied in molecular
biology and genetics.
Invariance of parameterization: Another area requiring further research is the in-
variance (or otherwise) of reparameterization. In his (2002) book, Wellek notes:
“... in contrast to the corresponding conventional testing problems with
the common boundary of null and alternative hypothesis [sic] being given by
zero, equivalence problems remain generally not invariant under redefinitions
of the main parameter.”
To illustrate this point, consider the problem of finding marker genes for day 3 in the
stem cell experiment. The criteria for such genes are: high gene expression level on
day 3, as well as equal and low gene expression levels on day 0, day 6 and day 9.
The requisite profile is illustrated in Figure 7. Examination of the profile reveals three
possible models:
µ =


1 0 0 0
1 1 -13 -
1
3
1 0 0 -1
1 0 -1 0

γ,µ =


1 0 0 0
1 1 -23
1
3
1 0 -1 1
1 0 -1 0

γ,µ =


1 0 0 0
1 1 -23 -
1
3
1 0 -1 0
1 0 -1 -1

γ,
where γ = (γ0, γ1, γ2, γ3)
′ with γ0 unrestrained, γ1 significantly positive, γ2 equivalent
to zero, and γ3 equivalent to zero.
The three models may not necessarily give the same results. This is because equiv-
alence is not transitive, i.e., if µ0 is equivalent to µ6, and µ6 is equivalent to µ9, it is
not necessarily true that µ0 is equivalent to µ9. This is because equivalence is defined
in a neighbourhood and so a “drift” resulting in µ0 and µ9 being too far apart to be
considered equivalent can occur. Methods to impose invariance are currently under in-
vestigation by the authors. Although this is an interesting area of research, invariance of
reparameterization does not limit the use of gene profiling. There are many pre-existing
statistical tests, e.g., the Wald test, that are not invariant under reparameterization. In
many cases, the research hypotheses will dictate the optimal model to use.
Applying gene profiling using limma: Gene profiling is easily implemented by fitting
the model to the data using limma and then calculating the U statistics. The calculation
of the U statistics was written in C to decrease the run time, but is easy to implement
in R.
To conclude, gene profiling introduces a flexible method to select genes for a pre-
specified time-course profile. Gene profiling is straightforward to implement in practice,
requiring only small modifications to the R package limma, and can be used to select for
14
most profiles of interest to biologists. The application of gene profiling in this article
has been to two-colour microarrays, but it could readily be modified for use for other
microarrays platforms, such as Affymetrix GeneChip (Lockhart et al., 1996), and for
other technologies where it is required to rank observations by correspondence with a
pre-specified profile.
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Figure 7: Hypothetical gene expression profile for a day 3 marker gene.
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